Results 201 to 210 of about 36,119 (263)

Efficacy, safety and economy of denosumab and zoledronic acid in the treatment of bone metastases of solid tumors and multiple myeloma: a systematic review and meta-analysis. [PDF]

Front Oncol
Zhong L, Chen W, Zheng D, Cao Y, Zhu L, Zhu Z, Liao L, Dai L, Wang X, Zeng Z.   +9 more
europepmc   +1 more source

Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX). [PDF]

ESMO Open
Link T, Reinisch M, Just M, Untch M, Filmann N, Stötzer O, Denkert C, Bjelic-Radisic V, Wimberger P, Thill M, Rhiem K, Huober J, Solbach C, Hanusch C, Engels K, Fasching PA, Schneeweiss A, Nekljudova V, Holtschmidt J, Blohmer JU, Loibl S.   +20 more
europepmc   +1 more source

Preliminary analysis of combined romosozumab and denosumab versus teriparatide and denosumab on bone mineral density. [PDF]

Osteoporos Sarcopenia
Chiang MH, Fan TS, Lee CC, Tseng TH, Yen HK, Hung CC, Lu YC, Sie NH, Wang CY, Fu SH.   +9 more
europepmc   +1 more source

Combined Approach (Surgery + Systemic Adjuvant Therapy) in a Giant Cell Tumor of Proximal Femur: A Rare Case Report. [PDF]

J Orthop Case Rep
Mohandas P, Magadum SD, Manickavasagam M.   +2 more
europepmc   +1 more source

Digital twin simulations with a micro-multiphysics agent-based model reveal key drivers of bone loss after denosumab discontinuation. [PDF]

Front Bioeng Biotechnol
Ledoux C, Kendall JJ, Boaretti D, Müller R, Collins CJ.   +4 more
europepmc   +1 more source

Postmenopausal Osteoporosis: From Molecular Pathways to Therapeutic Targets-A Mechanism-to-Practice Framework Integrating Pharmacotherapy, Fall Prevention, and Adherence into Patient-Centered Care. [PDF]

J Clin Med
Ena G, Soyfoo M.
europepmc   +1 more source

Efficacy and safety of curettage with bone grafting combined with denosumab in the treatment of distal radius giant cell tumor of bone. [PDF]

Medicine (Baltimore)
Yang H, Li S, Zhang Y, Wu S.
europepmc   +1 more source

Real-life use of bone-targeting agents for bone metastases in France between 2009 and 2018: Results of the OPTIMOS study. [PDF]

J Bone Oncol
Confavreux CB, Bouvard B, Girard N, Bosco-Levy P, Marchal C, Nolin M, Lehmann E, Desameric G, Belhassen M.   +8 more
europepmc   +1 more source

Medication-Related Osteonecrosis of the Jaw: An Evidence-Based 2025 Position Statement from a Korean Multidisciplinary Task Force. [PDF]

Endocrinol Metab (Seoul)
Kim JW, Kong SH, Kim JY, Kwak MK, Kim JY, Oh JH, Park HY, Kim B, Lee YK, Han JJ, Kim MY, Choi YJ, Kwon YD, Song KS, Kim BJ, Kim SJ, Baek SH, Lee DO, Choi HS, Kim HY, Kwon TG.   +20 more
europepmc   +1 more source